| 1 |
Fornasier M, Murgia S. Non-lamellar lipid liquid crystalline nanoparticles: A smart platform for nanomedicine applications. Front Soft Matter 2023;3. [DOI: 10.3389/frsfm.2023.1109508] [Reference Citation Analysis]
|
| 2 |
Deshmukh Shradha Suresh, Dr. Anil P. Dewani, Prof (Dr.) A. V. Chandewar. Cubosomes and its Pharmaceutical Application in Treatment of Cancer. IJARSCT 2023. [DOI: 10.48175/ijarsct-8628] [Reference Citation Analysis]
|
| 3 |
Makhlouf A, Elnawawy T. Hair regrowth boosting via minoxidil cubosomes: Formulation development, in vivo hair regrowth evaluation, histopathological examination and confocal laser microscopy imaging. Int J Pharm 2023;634:122665. [PMID: 36736676 DOI: 10.1016/j.ijpharm.2023.122665] [Reference Citation Analysis]
|
| 4 |
Seo Y, Lim H, Park H, Yu J, An J, Yoo HY, Lee T. Recent Progress of Lipid Nanoparticles-Based Lipophilic Drug Delivery: Focus on Surface Modifications. Pharmaceutics 2023;15:772. [DOI: 10.3390/pharmaceutics15030772] [Reference Citation Analysis]
|
| 5 |
Teixeira PV, Adega F, Martins-Lopes P, Machado R, Lopes CM, Lúcio M. pH-Responsive Hybrid Nanoassemblies for Cancer Treatment: Formulation Development, Optimization, and In Vitro Therapeutic Performance. Pharmaceutics 2023;15. [PMID: 36839648 DOI: 10.3390/pharmaceutics15020326] [Reference Citation Analysis]
|
| 6 |
Cai X, Fan B, Thang SH, Drummond CJ, Tran N, Zhai J. Paclitaxel-loaded cubosome lipid nanocarriers stabilised with pH and hydrogen peroxide-responsive steric stabilisers as drug delivery vehicles. J Mater Chem B 2023;11:403-14. [PMID: 36511883 DOI: 10.1039/d2tb01530g] [Reference Citation Analysis]
|
| 7 |
Ahmad A, Prakash R, Khan MS, Altwaijry N, Asghar MN, Raza SS, Khan R. Nanoparticle-Mediated PRDX2 Inhibition for Specific Targeting of CHK2-Null Colorectal Cancer. ACS Biomater Sci Eng 2022;8:5210-20. [PMID: 36446128 DOI: 10.1021/acsbiomaterials.2c01073] [Reference Citation Analysis]
|
| 8 |
Pramanik A, Xu Z, Ingram N, Coletta PL, Millner PA, Tyler AII, Hughes TA. Hyaluronic-Acid-Tagged Cubosomes Deliver Cytotoxics Specifically to CD44-Positive Cancer Cells. Mol Pharm 2022;19:4601-11. [PMID: 35938983 DOI: 10.1021/acs.molpharmaceut.2c00439] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 9 |
Vitoria Pupo Silvestrini A, Wender Debiasi B, Garcia Praça F, Vitoria Lopes Badra Bentley M. Progress and challenges of lyotropic liquid crystalline nanoparticles for innovative therapies. International Journal of Pharmaceutics 2022;628:122299. [DOI: 10.1016/j.ijpharm.2022.122299] [Reference Citation Analysis]
|
| 10 |
Mun H, Chaban Y, Tabish TA, Thorat N, Cowieson N, Owen CD, Townley HE. CD44 and CD221 directed magnetic cubosomes for the targeted delivery of helenalin to rhabdomyosarcoma cells. Nano Res 2022. [DOI: 10.1007/s12274-022-5037-4] [Reference Citation Analysis]
|
| 11 |
Umar H, Wahab HA, Gazzali AM, Tahir H, Ahmad W. Cubosomes: Design, Development, and Tumor-Targeted Drug Delivery Applications. Polymers 2022;14:3118. [DOI: 10.3390/polym14153118] [Reference Citation Analysis]
|
| 12 |
Oliveira C, Ferreira CJO, Sousa M, Paris JL, Gaspar R, Silva BFB, Teixeira JA, Ferreira-santos P, Botelho CM. A Versatile Nanocarrier—Cubosomes, Characterization, and Applications. Nanomaterials 2022;12:2224. [DOI: 10.3390/nano12132224] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 13 |
Shan X, Luo L, Yu Z, You J. Recent advances in versatile inverse lyotropic liquid crystals. J Control Release 2022;348:1-21. [PMID: 35636617 DOI: 10.1016/j.jconrel.2022.05.036] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 14 |
Alshawwa SZ, Kassem AA, Farid RM, Mostafa SK, Labib GS. Nanocarrier Drug Delivery Systems: Characterization, Limitations, Future Perspectives and Implementation of Artificial Intelligence. Pharmaceutics 2022;14:883. [PMID: 35456717 DOI: 10.3390/pharmaceutics14040883] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 15.0] [Reference Citation Analysis]
|
| 15 |
Almoshari Y. Development, Therapeutic Evaluation and Theranostic Applications of Cubosomes on Cancers: An Updated Review. Pharmaceutics 2022;14:600. [DOI: 10.3390/pharmaceutics14030600] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 16 |
Pramanik A, Xu Z, Shamsuddin SH, Khaled YS, Ingram N, Maisey T, Tomlinson D, Coletta PL, Jayne D, Hughes TA, Tyler AII, Millner PA. Affimer Tagged Cubosomes: Targeting of Carcinoembryonic Antigen Expressing Colorectal Cancer Cells Using In Vitro and In Vivo Models. ACS Appl Mater Interfaces 2022;14:11078-91. [PMID: 35196008 DOI: 10.1021/acsami.1c21655] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 12.0] [Reference Citation Analysis]
|
| 17 |
Tan C, Hosseini SF, Jafari SM. Cubosomes and Hexosomes as Novel Nanocarriers for Bioactive Compounds. J Agric Food Chem 2022. [PMID: 35089018 DOI: 10.1021/acs.jafc.1c06747] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 18 |
Cai X, Zhai J, Tran N, Mulet X, Drummond CJ. Lipid nanoparticle steric stabilization roadmap. Advances in Biomembranes and Lipid Self-Assembly 2022. [DOI: 10.1016/bs.abl.2022.05.003] [Reference Citation Analysis]
|
| 19 |
Marson D, Aulic S, Laurini E, Pricl S. Cubosomes: a promising vesicular system for drug delivery. Systems of Nanovesicular Drug Delivery 2022. [DOI: 10.1016/b978-0-323-91864-0.00021-8] [Reference Citation Analysis]
|
| 20 |
Varghese R, Salvi S, Sood P, Kulkarni B, Kumar D. Cubosomes in cancer drug delivery: A review. Colloid and Interface Science Communications 2022;46:100561. [DOI: 10.1016/j.colcom.2021.100561] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 21 |
Raza F, Zafar H, Khan MW, Ullah A, Khan AU, Baseer A, Fareed R, Sohail M. Recent advances in the targeted delivery of paclitaxel nanomedicine for cancer therapy. Mater Adv . [DOI: 10.1039/d1ma00961c] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 11.0] [Reference Citation Analysis]
|
| 22 |
Waheed A, Ahad A, Gupta DK, Aqil M, Al-jenoobi FI, Al-mohizea AM. Nanovesicles for the treatment of skin disorders. Applications of Nanovesicular Drug Delivery 2022. [DOI: 10.1016/b978-0-323-91865-7.00008-0] [Reference Citation Analysis]
|
| 23 |
Paterson DA, Fong WK, Hook S, Gamble AB. Hydrogen Sulfide-Responsive Bicontinuous Nanospheres. Biomacromolecules 2021;22:4770-82. [PMID: 34652153 DOI: 10.1021/acs.biomac.1c01070] [Reference Citation Analysis]
|
| 24 |
Alavi M, Nokhodchi A. Micro- and nanoformulations of paclitaxel based on micelles, liposomes, cubosomes, and lipid nanoparticles: Recent advances and challenges. Drug Discov Today 2021:S1359-6446(21)00445-1. [PMID: 34688912 DOI: 10.1016/j.drudis.2021.10.007] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 25 |
Zhai J, Yap SL, Drummond CJ, Tran N. Controlling the pH dependent transition between monoolein Fd3m micellar cubosomes and hexosomes using fatty acetate and fatty acid additive mixtures. J Colloid Interface Sci 2022;607:848-56. [PMID: 34536939 DOI: 10.1016/j.jcis.2021.08.173] [Reference Citation Analysis]
|
| 26 |
Ahmad A, Ansari MM, Verma RK, Khan R. Aminocellulose-Grafted Polymeric Nanoparticles for Selective Targeting of CHEK2-Deficient Colorectal Cancer. ACS Appl Bio Mater 2021;4:5324-35. [PMID: 35007013 DOI: 10.1021/acsabm.1c00437] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 27 |
Yaghmur A, Mu H. Recent advances in drug delivery applications of cubosomes, hexosomes, and solid lipid nanoparticles. Acta Pharm Sin B 2021;11:871-85. [PMID: 33996404 DOI: 10.1016/j.apsb.2021.02.013] [Cited by in Crossref: 35] [Cited by in F6Publishing: 39] [Article Influence: 17.5] [Reference Citation Analysis]
|
| 28 |
Zoabi A, Touitou E, Margulis K. Recent Advances in Nanomaterials for Dermal and Transdermal Applications. Colloids and Interfaces 2021;5:18. [DOI: 10.3390/colloids5010018] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 9.0] [Reference Citation Analysis]
|
| 29 |
Zhai J, Sarkar S, Conn CE, Drummond CJ. Molecular engineering of super-swollen inverse bicontinuous cubic and sponge lipid phases for biomedical applications. Mol Syst Des Eng 2020;5:1354-75. [DOI: 10.1039/d0me00076k] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
|
